Accreditation Information

Nurse Practitioners and Nurses: This activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for up to 1.0 contact hour, including up to 0.25 pharmacology hours. Credit can be applied toward the nursing continuing education requirements of most professional organizations and State Boards of Nursing.

Physicians: The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ARHP designates this internet enduring material for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Others: A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 Credit™.

Sponsoring Information

This program is sponsored by the Association of Reproductive Health Professionals.

Funding Information

This project is funded through educational grants from Bayer and Teva Pharmaceuticals.

Disclosure Information

All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

Advisory Committee Disclosures

  • Linda Dominguez, RN-C, NP (planner) is a consultant and master trainer for both Activis and Medicine 360.
  • Mark Hathaway, MD, MPH (planner) is a consultant for Afaxys, Actavis, ContraMed, and Medicine 360, and a trainer for Merck Nexplanon.
  • Anne Moore, DNP, APRN, FAANP (planner/faculty) is a speaker for Activis and Pfizer.
  • Lee Shulman, MD, FACOG, FACMG (planner) is a speaker and/or consultant for Activis, Teva, Merck, Bayer, Shionogi, Sequenom, Natera, Quest, and Roche Labs.  

ARHP Staff/Consultant Disclosures

  • Diane Shannon, MD (medical writer) and Rana Suliman, MPH (ARHP program manager) have nothing to disclose.